| 0 (0%) | 12-27 00:26 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 41.33 | 1-year : | 48.27 |
| Resists | First : | 35.38 | Second : | 41.33 |
| Pivot price | 32.41  |
|||
| Supports | First : | 29.38 |
Second : | 25.67 |
| MAs | MA(5) : | 33.6 |
MA(20) : | 32.08 |
| MA(100) : | 29.47 |
MA(250) : | 0 | |
| MACD | MACD : | 0.8 |
Signal : | 0.6 |
| %K %D | K(14,3) : | 64.3 |
D(3) : | 74.3 |
| RSI | RSI(14): 55.3 |
|||
| 52-week | High : | 55.33 | Low : | 23.29 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ TWST ] has closed below upper band by 35.4%. Bollinger Bands are 36.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 33.65 - 33.85 | 33.85 - 34 |
| Low: | 32.03 - 32.3 | 32.3 - 32.49 |
| Close: | 32.7 - 33.09 | 33.09 - 33.39 |
Wed, 24 Dec 2025
Twist Bioscience Corporation (NASDAQ:TWST) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Wed, 24 Dec 2025
New product launch strengthens bull case for Twist Bioscience (TWST) - MSN
Tue, 23 Dec 2025
Insider Selling: Twist Bioscience (NASDAQ:TWST) CEO Sells 1,605 Shares of Stock - MarketBeat
Tue, 23 Dec 2025
Twist Bioscience (NASDAQ:TWST) Insider Sells $11,197.44 in Stock - MarketBeat
Tue, 23 Dec 2025
Noteworthy ETF Outflows: ARKG, TEM, TWST, GH - Nasdaq
Tue, 23 Dec 2025
How Twist Bioscience Corporation (TWST) Affects Rotational Strategy Timing - Stock Traders Daily
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 61 (M) |
| Shares Float | 56 (M) |
| Held by Insiders | 2.5 (%) |
| Held by Institutions | 119.7 (%) |
| Shares Short | 12,750 (K) |
| Shares Short P.Month | 10,550 (K) |
| EPS | -1.3 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 7.8 |
| Profit Margin | -20.7 % |
| Operating Margin | -30.3 % |
| Return on Assets (ttm) | -13.6 % |
| Return on Equity (ttm) | -16.5 % |
| Qtrly Rev. Growth | 16.8 % |
| Gross Profit (p.s.) | 3.12 |
| Sales Per Share | 6.15 |
| EBITDA (p.s.) | -1.87 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -48 (M) |
| Levered Free Cash Flow | -33 (M) |
| PE Ratio | -25.43 |
| PEG Ratio | 0 |
| Price to Book value | 4.23 |
| Price to Sales | 5.36 |
| Price to Cash Flow | -42.44 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|